CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 80 filers reported holding CATALYST BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,830,000 | -18.7% | 2,635,014 | -14.3% | 4.93% | -29.3% |
| Q2 2021 | $13,321,000 | +7.9% | 3,076,376 | +25.6% | 6.97% | +4.4% |
| Q1 2021 | $12,349,000 | +134.5% | 2,450,193 | +193.6% | 6.67% | +65.5% |
| Q4 2020 | $5,265,000 | -13.2% | 834,449 | -40.9% | 4.03% | -36.1% |
| Q3 2020 | $6,069,000 | +88.8% | 1,411,412 | +157.8% | 6.31% | +1.4% |
| Q2 2020 | $3,214,000 | -27.8% | 547,541 | -46.3% | 6.22% | +32.2% |
| Q1 2020 | $4,454,000 | +112.8% | 1,019,196 | +231.7% | 4.71% | +222.8% |
| Q4 2019 | $2,093,000 | – | 307,287 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |